Clinical trial of SPI 1972, a fixed combination of selegiline and a phosphodiesterase-5 inhibitor, for the treatment of erectile dysfunction.
Phase of Trial: Clinical Phase Unknown
Latest Information Update: 12 Sep 2011
At a glance
- Drugs SPI 1972 (Primary)
- Indications Erectile dysfunction
- Focus Therapeutic Use
- 12 Sep 2011 New trial record